Baidu
map
NEUROUROL URODYNAM 润色咨询

NEUROUROLOGY AND URODYNAMICS

出版年份：1982 年文章数：3799 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：21.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2024-09-05 ms5000000411443294 来自贵州省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：印戒细胞癌;综述;临床
    经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2024-07-22 ms4000001373859908 来自广东省

    这个审稿要多久啊？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2022-02-08 146ca191m99暂无昵称

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：基础
    经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    引言中是否可以引用非常老的文章？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    引言和讨论的区别？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验求分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2224271, encodeId=b3b422242e1c1, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：印戒细胞癌;综述;临床<br>经验分享：有一篇偏临床的综述，关于印戒细胞癌，希望能找到一个合适的期刊，分值在1-2分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3e9452063, createdName=ms5000000411443294, createdTime=Thu Sep 05 16:06:43 CST 2024, time=2024-09-05, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216297, encodeId=2ede221629ebc, content=这个审稿要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Mon Jul 22 17:34:17 CST 2024, time=2024-07-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191168, encodeId=7a36119116841, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：基础<br>经验分享：审稿很快，审稿意见中肯，大修1次，小修2次吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c485166643, createdName=146ca191m99暂无昵称, createdTime=Tue Feb 08 20:11:16 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095965, encodeId=e5a8109596573, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095966, encodeId=37dc10959667f, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578673, encodeId=801f5e867381, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492500, encodeId=c465492500eb, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

共13条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map